NP
Natsar Pharmaceuticals, Inc.
SEC filingPharmaceuticals · Ellicott City, MD
Amount raised$4.2Msold at filing
Total offeringNot stated
Investors in the raise15count reported to the SEC
FiledMay 8, 2026first sale Apr 23, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Venu RamanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.